A Novel CD44-binding Peptide from the Pro-Matrix Metalloproteinase-9 Hemopexin Domain Impairs Adhesion and Migration of Chronic Lymphocytic Leukemia (CLL) Cells
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A Novel CD44-binding Peptide from the Pro-Matrix Metalloproteinase-9 Hemopexin Domain Impairs Adhesion and Migration of Chronic Lymphocytic Leukemia (CLL) Cells
Authors
Keywords
-
Journal
JOURNAL OF BIOLOGICAL CHEMISTRY
Volume 289, Issue 22, Pages 15340-15349
Publisher
American Society for Biochemistry & Molecular Biology (ASBMB)
Online
2014-04-17
DOI
10.1074/jbc.m114.559187
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Overexpression of progelatinase B/proMMP-9 affects migration regulatory pathways and impairs chronic lymphocytic leukemia cell homing to bone marrow and spleen
- (2014) E. Bailon et al. JOURNAL OF LEUKOCYTE BIOLOGY
- CD44 regulates the apoptotic response and promotes disease development in chronic lymphocytic leukemia
- (2013) O. Fedorchenko et al. BLOOD
- Biochemistry and molecular biology of gelatinase B or matrix metalloproteinase-9 (MMP-9): The next decade
- (2013) Jennifer Vandooren et al. CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY
- Targeting chronic lymphocytic leukemia cells with a humanized monoclonal antibody specific for CD44
- (2013) S. Zhang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- CD40-Mediated Activation of Chronic Lymphocytic Leukemia Cells Promotes Their CD44-Dependent Adhesion to Hyaluronan and Restricts CCL21-Induced Motility
- (2012) T. Girbl et al. CANCER RESEARCH
- Novel MT1-MMP Small-Molecule Inhibitors Based on Insights into Hemopexin Domain Function in Tumor Growth
- (2012) A. G. Remacle et al. CANCER RESEARCH
- A 17-residue Sequence from the Matrix Metalloproteinase-9 (MMP-9) Hemopexin Domain Binds α4β1 Integrin and Inhibits MMP-9-induced Functions in Chronic Lymphocytic Leukemia B Cells
- (2012) Estefanía Ugarte-Berzal et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Small-Molecule Anticancer Compounds Selectively Target the Hemopexin Domain of Matrix Metalloproteinase-9
- (2011) A. Dufour et al. CANCER RESEARCH
- Inhibition of Matrix Metalloproteinase 14 (MMP-14)-mediated Cancer Cell Migration
- (2011) Kevin Zarrabi et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Activation of CD44, a receptor for extracellular matrix components, protects chronic lymphocytic leukemia cells from spontaneous and drug induced apoptosis through MCL-1
- (2011) Yair Herishanu et al. LEUKEMIA & LYMPHOMA
- Matrix Metalloproteinase-9 Promotes Chronic Lymphocytic Leukemia B Cell Survival through Its Hemopexin Domain
- (2010) Javier Redondo-Muñoz et al. CANCER CELL
- Matrix Metalloproteinases: Regulators of the Tumor Microenvironment
- (2010) Kai Kessenbrock et al. CELL
- Role of Matrix Metalloproteinase-9 Dimers in Cell Migration
- (2010) Antoine Dufour et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Molecular and cellular mechanisms of CLL: novel therapeutic approaches
- (2009) Lisa Pleyer et al. Nature Reviews Clinical Oncology
- 4 1 integrin and 190-kDa CD44v constitute a cell surface docking complex for gelatinase B/MMP-9 in chronic leukemic but not in normal B cells
- (2008) J. Redondo-Munoz et al. BLOOD
- CD49d expression is an independent predictor of overall survival in patients with chronic lymphocytic leukaemia: a prognostic parameter with therapeutic potential
- (2008) Tait D. Shanafelt et al. BRITISH JOURNAL OF HAEMATOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started